Medronic Acid

Medronic Acid

SCHEMBL2638879

O=P([O-])([O-])CP(=O)([O-])O.[Na+].[Na+].[Na+]

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Medronic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
THRB known ✓ P10828 1/20 0.39
SLC34A1 Q06495 1/20 0.41
KDM4E B2RXH2 2/20 0.39
MMP2 P08253 1/20 0.39
MAPK1 P28482 1/20 0.39
HSD17B10 Q99714 1/20 0.39
CYP2C19 P33261 1/20 0.36
KMT2A Q03164 1/20 0.36
LMNA P02545 2/20 0.35
BTN3A1 O00481 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Medronic Acid SCHEMBL7929832 0.93 SLC34A1 (0.50) SLC34A1KDM4EMMP2THRBMAPK1
Medronic Acid SCHEMBL133343 0.86 SLC34A1 (0.47) SLC34A1KDM4EMMP2THRBMAPK1
Medronic Acid SCHEMBL4605897 0.80 KDM4E (0.56) SLC34A1KDM4EMMP2THRBMAPK1
Medronic Acid SCHEMBL409013 0.78 LMNA (0.35) SLC34A1KDM4EMMP2THRBMAPK1
Medronic Acid SCHEMBL27363301 0.78 KDM4E (0.53) SLC34A1KDM4EMMP2THRBMAPK1
Medronic Acid SCHEMBL5272656 0.74 LMNA (0.33) SLC34A1LMNABTN3A1
Medronic Acid SCHEMBL2801380 0.70 SLC34A1 (0.33) SLC34A1KDM4EMMP2THRBMAPK1
Medronic Acid SCHEMBL9645616 0.70 SLC34A1 (0.33) SLC34A1KDM4EMMP2THRBMAPK1
Medronic Acid SCHEMBL8712848 0.70 SLC34A1 (0.33) SLC34A1KDM4EMMP2THRBMAPK1
Medronic Acid SCHEMBL5423104 0.70 SLC34A1 (0.33) SLC34A1KDM4EMMP2THRBMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2670887-B1 ADHESION PROMOTING COMPOSITION FOR METAL LEADFRAMES MACDERMID ACUMEN INC (US) 2021-11-03 EP claimed
US-10427978-B2 Coated building panels and articles containing calcium sulfate hemihydrate UNITED STATES GYPSUM COMPANY (US) 2019-10-01 US claimed
US-9919969-B2 Coated building panels and articles containing calcium sulfate hemihydrate UNITED STATES GYPSUM COMPANY (US) 2018-03-20 US claimed
EP-1278709-B1 GYPSUM COMPOSITIONS WITH ENHANCED RESISTANCE TO PERMANENT DEFORMATION UNITED STATES GYPSUM CO (US) 2018-01-03 EP claimed
US-20160355438-A1 COATED BUILDING PANELS AND ARTICLES CONTAINING CALCIUM SULFATE HEMIHYDRATE UNITED STATES GYPSUM COMPANY 2016-12-08 US claimed
EP-2297257-B1 COATED BUILDING PANELS AND ARTICLES CONTAINING CALCIUM SULFATE HEMIHYDRATE KNAUF GIPS KG (DE) 2016-06-08 EP claimed
CN-103339289-B Metal lead wire frame is with increasing glutinous composition MACDERMID ACUMEN, INC. (US) 2016-02-10 CN claimed
EP-2670887-A1 ADHESION PROMOTING COMPOSITION FOR METAL LEADFRAMES MacDermid Acumen, Inc. (US) 2013-12-11 EP claimed
US-20130312635-A1 Adhesion Promoting Composition for Metal Leadframes MacDermind Acumen, Inc. (US) 2013-11-28 US claimed
US-8563139-B2 Non-hydrating plaster composition and method UNITED STATES GYPSUM COMPANY (US) 2013-10-22 US claimed
JP-2011518105-A 2011-06-23 JP claimed
CN-102015928-A Coated building panels and articles containing calcium sulfate hemihydrate UNITED STATES GYPSUM CO 2011-04-13 CN claimed
WO-2009151724-A2 COATED BUILDING PANELS AND ARTICLES CONTAINING CALCIUM SULFATE HEMIHYDRATE UNITED STATES GYPSUM COMPANY (US) 2009-12-17 WO claimed
US-20090264556-A1 NON-HYDRATING PLASTER COMPOSITION AND METHOD UNITED STATES GYPSUM COMPANY 2009-10-22 US claimed
US-20090263673-A1 COATED BUILDING PANELS AND ARTICLES CONTAINING CALCIUM SULFATE HEMIHYDRATE UNITED STATES GYPSUM COMPANY 2009-10-22 US claimed
US-6852495-B2 Process of extracting nucleic acid and process of simultaneously carrying out extraction and purification of nucleic acid SHIMADZU CORPORATION (JP) 2005-02-08 US claimed
EP-1278709-A4 GYPSUM COMPOSITIONS WITH ENHANCED RESISTANCE TO PERMANENT DEFORMATION UNITED STATES GYPSUM CO (US) 2005-01-19 EP claimed
CN-1400958-A Gypsum compositions having enhanced resistance to permanent deformation US CYPSUM CO (US) 2003-03-05 CN claimed
EP-1278709-A1 GYPSUM COMPOSITIONS WITH ENHANCED RESISTANCE TO PERMANENT DEFORMATION UNITED STATES GYPSUM COMPANY (US) 2003-01-29 EP claimed
WO-2001081263-A1 GYPSUM COMPOSITIONS WITH ENHANCED RESISTANCE TO PERMANENT DEFORMATION UNITED STATES GYPSUM COMPANY (US) 2001-11-01 WO claimed